Report Detail
Global Anti-Obesity Drugs (Anti-obesity Medication) Market Insights and Forecast to 2026
- RnM4158635 |
- 25 August, 2020 |
- Global |
- 148 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Obesity Drugs (Anti-obesity Medication) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Drugs (Anti-obesity Medication) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Obesity Drugs (Anti-obesity Medication) market is segmented into
by Drug Varieties
Prescription Drugs
OTC Drugs
by Acting
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application, the Anti-Obesity Drugs (Anti-obesity Medication) market is segmented into
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Regional and Country-level Analysis
The Anti-Obesity Drugs (Anti-obesity Medication) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Obesity Drugs (Anti-obesity Medication) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Obesity Drugs (Anti-obesity Medication) Market Share Analysis
Anti-Obesity Drugs (Anti-obesity Medication) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Obesity Drugs (Anti-obesity Medication) business, the date to enter into the Anti-Obesity Drugs (Anti-obesity Medication) market, Anti-Obesity Drugs (Anti-obesity Medication) product introduction, recent developments, etc.
The major vendors covered:
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
1 Study Coverage
- 1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type
- 1.4.2 Prescription Drugs
- 1.4.3 OTC Drugs
- 1.5 Market by Application
- 1.5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Application
- 1.5.2 Childhood (0-6)
- 1.5.3 Juvenile (7-17)
- 1.5.4 Youth (18-40)
- 1.5.5 Middle Aged (41-60)
- 1.5.6 Elderly (Above 60)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue 2015-2026
- 2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales 2015-2026
- 2.2 Global Anti-Obesity Drugs (Anti-obesity Medication), Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Obesity Drugs (Anti-obesity Medication) Competitor Landscape by Players
- 3.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers
- 3.1.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers
- 3.2.1 Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2019
- 3.2.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Obesity Drugs (Anti-obesity Medication) Price by Manufacturers
- 3.4 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Obesity Drugs (Anti-obesity Medication) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2015-2020)
- 4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2015-2020)
- 4.1.3 Anti-Obesity Drugs (Anti-obesity Medication) Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Obesity Drugs (Anti-obesity Medication) Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2015-2020)
- 5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2015-2020)
- 5.1.3 Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2015-2020)
- 5.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Obesity Drugs (Anti-obesity Medication) by Country
- 6.1.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
- 6.1.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Type
- 6.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) by Country
- 7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
- 7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Type
- 7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) by Region
- 8.1.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
- 8.1.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) by Country
- 9.1.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
- 9.1.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Type
- 9.3 Central & South America Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) by Country
- 10.1.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
- 10.1.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 UAE
- 10.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Facts & Figures by Application
11 Company Profiles
- 11.1 Zafgan
- 11.1.1 Zafgan Corporation Information
- 11.1.2 Zafgan Description and Business Overview
- 11.1.3 Zafgan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.1.5 Zafgan Related Developments
- 11.2 Vivus
- 11.2.1 Vivus Corporation Information
- 11.2.2 Vivus Description and Business Overview
- 11.2.3 Vivus Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.2.5 Vivus Related Developments
- 11.3 Shionogi
- 11.3.1 Shionogi Corporation Information
- 11.3.2 Shionogi Description and Business Overview
- 11.3.3 Shionogi Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.3.5 Shionogi Related Developments
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description and Business Overview
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.4.5 Sanofi Related Developments
- 11.5 Rhythm Pharmaceuticals
- 11.5.1 Rhythm Pharmaceuticals Corporation Information
- 11.5.2 Rhythm Pharmaceuticals Description and Business Overview
- 11.5.3 Rhythm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.5.5 Rhythm Pharmaceuticals Related Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Corporation Information
- 11.6.2 Pfizer Description and Business Overview
- 11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.6.5 Pfizer Related Developments
- 11.7 Orexigen Therapeutics
- 11.7.1 Orexigen Therapeutics Corporation Information
- 11.7.2 Orexigen Therapeutics Description and Business Overview
- 11.7.3 Orexigen Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.7.5 Orexigen Therapeutics Related Developments
- 11.8 Novo Nordisk
- 11.8.1 Novo Nordisk Corporation Information
- 11.8.2 Novo Nordisk Description and Business Overview
- 11.8.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.8.5 Novo Nordisk Related Developments
- 11.9 Norgine
- 11.9.1 Norgine Corporation Information
- 11.9.2 Norgine Description and Business Overview
- 11.9.3 Norgine Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.9.5 Norgine Related Developments
- 11.10 Nalpropion Pharmaceuticals Inc.
- 11.10.1 Nalpropion Pharmaceuticals Inc. Corporation Information
- 11.10.2 Nalpropion Pharmaceuticals Inc. Description and Business Overview
- 11.10.3 Nalpropion Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.10.5 Nalpropion Pharmaceuticals Inc. Related Developments
- 11.1 Zafgan
- 11.1.1 Zafgan Corporation Information
- 11.1.2 Zafgan Description and Business Overview
- 11.1.3 Zafgan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Products Offered
- 11.1.5 Zafgan Related Developments
- 11.12 GlaxoSmithKline
- 11.12.1 GlaxoSmithKline Corporation Information
- 11.12.2 GlaxoSmithKline Description and Business Overview
- 11.12.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 GlaxoSmithKline Products Offered
- 11.12.5 GlaxoSmithKline Related Developments
- 11.13 F.Hoffmann-La Roche
- 11.13.1 F.Hoffmann-La Roche Corporation Information
- 11.13.2 F.Hoffmann-La Roche Description and Business Overview
- 11.13.3 F.Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 F.Hoffmann-La Roche Products Offered
- 11.13.5 F.Hoffmann-La Roche Related Developments
- 11.14 Eisai
- 11.14.1 Eisai Corporation Information
- 11.14.2 Eisai Description and Business Overview
- 11.14.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Eisai Products Offered
- 11.14.5 Eisai Related Developments
- 11.15 Boehringer Ingelheim
- 11.15.1 Boehringer Ingelheim Corporation Information
- 11.15.2 Boehringer Ingelheim Description and Business Overview
- 11.15.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Boehringer Ingelheim Products Offered
- 11.15.5 Boehringer Ingelheim Related Developments
- 11.16 Bayer AG
- 11.16.1 Bayer AG Corporation Information
- 11.16.2 Bayer AG Description and Business Overview
- 11.16.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Bayer AG Products Offered
- 11.16.5 Bayer AG Related Developments
- 11.17 AstraZeneca
- 11.17.1 AstraZeneca Corporation Information
- 11.17.2 AstraZeneca Description and Business Overview
- 11.17.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 AstraZeneca Products Offered
- 11.17.5 AstraZeneca Related Developments
- 11.18 Arena Pharmaceuticals
- 11.18.1 Arena Pharmaceuticals Corporation Information
- 11.18.2 Arena Pharmaceuticals Description and Business Overview
- 11.18.3 Arena Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Arena Pharmaceuticals Products Offered
- 11.18.5 Arena Pharmaceuticals Related Developments
- 11.19 Amylin
- 11.19.1 Amylin Corporation Information
- 11.19.2 Amylin Description and Business Overview
- 11.19.3 Amylin Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Amylin Products Offered
- 11.19.5 Amylin Related Developments
- 11.20 Alizyme
- 11.20.1 Alizyme Corporation Information
- 11.20.2 Alizyme Description and Business Overview
- 11.20.3 Alizyme Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Alizyme Products Offered
- 11.20.5 Alizyme Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Estimates and Projections by Region
- 12.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Obesity Drugs (Anti-obesity Medication) Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Obesity Drugs (Anti-obesity Medication) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Obesity Drugs (Anti-obesity Medication) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Obesity Drugs (Anti-obesity Medication). Industry analysis & Market Report on Anti-Obesity Drugs (Anti-obesity Medication) is a syndicated market report, published as Global Anti-Obesity Drugs (Anti-obesity Medication) Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-Obesity Drugs (Anti-obesity Medication) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
